UNH Margin Recovery Fuels Earnings Growth into 2027 and 2028

UnitedHealth Group (UNH) is experiencing a significant turnaround in its operational performance. The company's margin recovery in both UnitedHealthcare and Optum Health segments has been impressive, with revenue reaching $112 billion in Q2 and adjusted earnings per share (EPS) of $6.38. Management's efforts to control costs, reset contracts, and implement technology-driven efficiencies are driving sustainable margin expansion and earnings growth into 2027 and 2028.

The company's financials show a strong year-over-year margin improvement across key divisions, with management attributing this success to their cost controls and contract resets. UnitedHealth Group also offers a 2.46% dividend yield and ongoing buybacks, supporting a Buy rating with attractive risk-reward.

Investors are taking note of UNH's improving results, which have been affected by the tough last year. The company's recovery in Medicare Advantage profitability is due to pricing, benefit structure, care management, and network initiatives taking hold. Optum Health is also contributing to the turnaround, with its strong performance driving overall growth.